Revance Therapeutics, Inc. Competitors
Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|---|
ACLX
|
Arcellx, Inc. | $78.20 | $2.72 B | -49.3 | 130 | $110.32 M |
AKRO
|
Akero Therapeutics, Inc. | $28.25 | $1.59 B | -7.1 | 61 | $0 |
AMLX
|
Amylyx Pharmaceuticals, Inc. | $3.14 | $120.37 M | -1.65 | 384 | $380.79 M |
APLS
|
Apellis Pharmaceuticals, Inc. | $27.52 | $4.90 B | -11.77 | 702 | $396.59 M |
BPMC
|
Blueprint Medicines Corporation | $88.58 | $6.47 B | -21.48 | 638 | $249.38 M |
CERE
|
Cerevel Therapeutics Holdings, Inc. | $44.96 | $7.29 B | -14.66 | 355 | $0 |
DAWN
|
Day One Biopharmaceuticals, Inc. | $14.10 | $1.12 B | -5.11 | 169 | $0 |
DMAC
|
DiaMedica Therapeutics Inc. | $4.36 | $97.19 M | -4.74 | 18 | $0 |
ETNB
|
89bio, Inc. | $7.19 | $796.91 M | -4.05 | 70 | $0 |
IMCR
|
Immunocore Holdings plc | $31.11 | $2.08 B | -26.72 | 497 | $249.43 M |
ISEE
|
IVERIC bio, Inc. | $39.95 | $5.51 B | -22.44 | 163 | $0 |
KRTX
|
Karuna Therapeutics, Inc. | $329.83 | $12.60 B | -28.09 | 339 | $654,000 |
MDGL
|
Madrigal Pharmaceuticals, Inc. | $208.36 | $5.21 B | -10.55 | 376 | $0 |
NUVL
|
Nuvalent, Inc. | $105.09 | $5.11 B | -32.72 | 115 | $0 |
PLRX
|
Pliant Therapeutics, Inc. | $11.53 | $672.63 M | -3.9 | 166 | $1.58 M |
STOK
|
Stoke Therapeutics, Inc. | $11.72 | $774.50 M | -6.14 | 110 | $8.78 M |
TERN
|
Terns Pharmaceuticals, Inc. | $8.29 | $462.44 M | -5.67 | 66 | $0 |
VTYX
|
Ventyx Biosciences, Inc. | $2.12 | $229.83 M | -1.01 | 73 | $0 |